glp-1 colorectal cancer death risk study november 2025 Could GLP-1s have an impact on colon risk? New data is promising. bit.ly/3NjW0wd Recent data suggests people taking drugs may develop cancer less often than those taking aspirin, a GLP-1 receptor agonists—the class of

Weight loss momentum continues, and resuming your established dose allows you to return to your treatment plan without significant setback

Plasma free fatty acids and risk of heart failure: the cardiovascular health study

The short answer is that combination therapy is possible but requires close medical supervision, as these drug classes work through differentand sometimes opposingmetabolic pathways

The most useful way to think about injection site reactions is to separate short-lived irritation from signs of infection, allergy, or a pattern that keeps coming back in the same spot

3.2 Second-generation long-acting analogs The evolution developed with the emergence of second-generation GLP-1 receptor agonists, suggesting a notable advancement in molecular design and clinical application